Clinical Trial Update: Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating response-based chemotherapy in younger patients with Down syndrome who have newly diagnosed acute myeloid leukemia or myelodysplastic s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Down Syndrome
• Myelodysplastic Syndrome
• Myeloid Leukemia Associated with Down Syndrome
• Myeloproliferative Neoplasm

Snippet

Sponsor: Children's Oncology Group | Conditions: Acute Myeloid Leukemia, Down Syndrome | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-06-13